Search research articles
Contact Us
Filters
Showing results (101-110 of 119) with videos related to
Page
of 12
Sort By:
Journal of Pediatric Hematology/Oncology
|
August 4, 2009
Quality control of flow cytometry data analysis for evaluation of minimal residual disease in bone marrow from acute leukemia patients during treatment
Elisabet Björklund, Irma Matinlauri, Anne Tierens, et al.
Haematologica
|
February 9, 2012
Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study
Matteo G Della Porta, Cristina Picone, Cristiana Pascutto, et al.
British Journal of Haematology
|
October 30, 2009
High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus
Sylvia Hartmann, Stefan Gesk, René Scholtysik, et al.
The American Journal of Surgical Pathology
|
April 1, 2011
Diagnosis and immunophenotype of 188 pediatric lymphoblastic lymphomas treated within a randomized prospective trial: experiences and preliminary recommendations from the European childhood lymphoma pathology panel
Ilske Oschlies, Birgit Burkhardt, Catherine Chassagne-Clement, et al.
Haematologica
|
April 1, 2014
p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)
Leonie Saft, Mohsen Karimi, Mehran Ghaderi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2007
Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following myelodysplastic syndrome
Michael Grövdal, Rasheed Khan, Anni Aggerholm, et al.
British Journal of Haematology
|
September 4, 2010
A European consensus report on blood cell identification: terminology utilized and morphological diagnosis concordance among 28 experts from 17 countries within the European LeukemiaNet network WP10, on behalf of the ELN Morphology Faculty
Gina Zini, Barbara Bain, Peter Bettelheim, et al.
Blood
|
March 15, 2003
Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma
Sarah H Walsh, Mia Thorsélius, Anna Johnson, et al.
British Journal of Haematology
|
January 22, 2011
Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry
Ingrid Thörn, Erik Forestier, Johan Botling, et al.
Haematologica
|
July 2, 2011
Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
Lars Möllgård, Leonie Saft, Marianne Bach Treppendahl, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 119) with videos related to
Sort By:
Page
of 12
Journal of Pediatric Hematology/Oncology
|
August 4, 2009
Quality control of flow cytometry data analysis for evaluation of minimal residual disease in bone marrow from acute leukemia patients during treatment
Elisabet Björklund, Irma Matinlauri, Anne Tierens, et al.
Haematologica
|
February 9, 2012
Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study
Matteo G Della Porta, Cristina Picone, Cristiana Pascutto, et al.
British Journal of Haematology
|
October 30, 2009
High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus
Sylvia Hartmann, Stefan Gesk, René Scholtysik, et al.
The American Journal of Surgical Pathology
|
April 1, 2011
Diagnosis and immunophenotype of 188 pediatric lymphoblastic lymphomas treated within a randomized prospective trial: experiences and preliminary recommendations from the European childhood lymphoma pathology panel
Ilske Oschlies, Birgit Burkhardt, Catherine Chassagne-Clement, et al.
Haematologica
|
April 1, 2014
p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)
Leonie Saft, Mohsen Karimi, Mehran Ghaderi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2007
Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following myelodysplastic syndrome
Michael Grövdal, Rasheed Khan, Anni Aggerholm, et al.
British Journal of Haematology
|
September 4, 2010
A European consensus report on blood cell identification: terminology utilized and morphological diagnosis concordance among 28 experts from 17 countries within the European LeukemiaNet network WP10, on behalf of the ELN Morphology Faculty
Gina Zini, Barbara Bain, Peter Bettelheim, et al.
Blood
|
March 15, 2003
Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma
Sarah H Walsh, Mia Thorsélius, Anna Johnson, et al.
British Journal of Haematology
|
January 22, 2011
Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry
Ingrid Thörn, Erik Forestier, Johan Botling, et al.
Haematologica
|
July 2, 2011
Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
Lars Möllgård, Leonie Saft, Marianne Bach Treppendahl, et al.
Page
of 12